Redox balance in patients with Down's syndrome before and after dietary supplementation with alpha-lipoic acid and L-cysteine.

W Gualandri, L Gualandri, G Demartini, R Esposti, P Marthyn, S Volontè, L Stangoni, M Borgonovo, F Fraschini
{"title":"Redox balance in patients with Down's syndrome before and after dietary supplementation with alpha-lipoic acid and L-cysteine.","authors":"W Gualandri,&nbsp;L Gualandri,&nbsp;G Demartini,&nbsp;R Esposti,&nbsp;P Marthyn,&nbsp;S Volontè,&nbsp;L Stangoni,&nbsp;M Borgonovo,&nbsp;F Fraschini","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of the present study was to investigate the possible normalizing effect of antioxidants on certain parameters indicative of oxidative stress in Down's syndrome (DS). The study was performed in pediatric patients with DS with proven redox imbalance, who were advised to take a dietary supplementation composed of alpha-lipoic acid and L-cysteine for several treatment cycles (one treatment cycle = 30 days dietary supplementation plus 30 days wash-out). Serum thiol groups, serum total and septic reactive oxygen species (ROS) and total antioxidant status of serum were determined before and after dietary supplementation, using commercially available kits. In all the evaluable patients (n = 20), after 3.8 +/- 1.1 treatment cycles, thiol group serum concentrations and total antioxidant status of serum significantly increased (p < 0.0001 for both parameters) in comparison with basal values, while serum total and septic ROS significantly decreased (p < 0.0001 for both parameters). On the basis of these results it is impossible to demonstrate the clinical effects of the biochemical normalization obtained in patients with DS after supplying alpha-lipoic acid and L-cysteine. These data suggest that delaying the clinical expression of redox imbalance in patients with DS might be feasible by normalizing their redox balance.</p>","PeriodicalId":13940,"journal":{"name":"International journal of clinical pharmacology research","volume":"23 1","pages":"23-30"},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of clinical pharmacology research","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of the present study was to investigate the possible normalizing effect of antioxidants on certain parameters indicative of oxidative stress in Down's syndrome (DS). The study was performed in pediatric patients with DS with proven redox imbalance, who were advised to take a dietary supplementation composed of alpha-lipoic acid and L-cysteine for several treatment cycles (one treatment cycle = 30 days dietary supplementation plus 30 days wash-out). Serum thiol groups, serum total and septic reactive oxygen species (ROS) and total antioxidant status of serum were determined before and after dietary supplementation, using commercially available kits. In all the evaluable patients (n = 20), after 3.8 +/- 1.1 treatment cycles, thiol group serum concentrations and total antioxidant status of serum significantly increased (p < 0.0001 for both parameters) in comparison with basal values, while serum total and septic ROS significantly decreased (p < 0.0001 for both parameters). On the basis of these results it is impossible to demonstrate the clinical effects of the biochemical normalization obtained in patients with DS after supplying alpha-lipoic acid and L-cysteine. These data suggest that delaying the clinical expression of redox imbalance in patients with DS might be feasible by normalizing their redox balance.

膳食补充α -硫辛酸和l -半胱氨酸前后唐氏综合征患者的氧化还原平衡。
本研究的目的是探讨抗氧化剂对唐氏综合征(DS)中氧化应激的某些参数可能的正常化作用。该研究是在证实氧化还原失衡的儿童DS患者中进行的,他们被建议在几个治疗周期内服用由α -硫辛酸和l -半胱氨酸组成的膳食补充剂(一个治疗周期= 30天膳食补充剂加上30天洗脱期)。采用市售试剂盒测定饲粮添加前后血清硫醇组、血清总活性氧和脓毒性活性氧(ROS)及血清总抗氧化状态。在所有可评估的患者(n = 20)中,经过3.8 +/- 1.1个治疗周期后,与基础值相比,血清硫醇组血清浓度和血清总抗氧化状态显著升高(两项参数均p < 0.0001),而血清总ROS和脓毒性ROS显著降低(两项参数均p < 0.0001)。在这些结果的基础上,不可能证明提供α -硫辛酸和l -半胱氨酸后获得的DS患者生化正常化的临床效果。这些数据表明,通过使DS患者的氧化还原平衡正常化,延缓其氧化还原失衡的临床表达可能是可行的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信